Cell surface Fc receptor for IgM antibody (FcμR) is the most recently identified member among FcRs. We determined the cellular distribution of mouse FcμR and the functional consequences of Fcmr disruption. Surface FcμR expression was restricted to B-lineage cells, from immature B to plasma cells, except for a transient downmodulation during germinal center reactions. Fcmr ablation had no significant effect on overall B-and T-cell development, but led to a reduction of marginal zone B cells and an increase in splenic B1 B cells. Preimmune serum IgM in mutant mice was significantly elevated as were natural autoantibodies. When immunized with live attenuated pneumococci, mutant mice mounted robust antibody responses against phosphorylcholine, but not protein, determinants compared with wild-type mice. By contrast, upon immunization with a hapten-carrier conjugate, nitrophenyl-coupled chicken γ-globulin (NP-CGG), the mutant mice had a diminished primary IgG1 response to both NP and CGG. These findings suggest that FcμR has an important role in IgM homeostasis and regulation of humoral immune responses.
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natural antibody | B-cell tolerance | B-cell subset | autoimmunity I gM is the first Ig isotype to appear during phylogeny, ontogeny, and the immune response (1) . The importance of both preimmune "natural" IgM and antigen (Ag)-induced immune IgM Abs in protection against infection and autoimmune diseases have been established through studies of mutant mice deficient in IgM secretion (2, 3) . Naïve B cells in these mice express membranebound IgM and, following Ag challenge, can undergo Ig isotype switching to other Ig isotypes that can be secreted. However, these animals are unable to control viral, bacterial, and fungal infections due to lack of serum IgM and an unexpected inefficient induction of a protective IgG Ab response (4) (5) (6) . Autoimmune pathology associated with IgG autoantibodies is exacerbated in these mutant mice, possibly because of impaired clearance of autoantigen-expressing apoptotic cells (7, 8) . Secreted IgM can thus profoundly influence immune responses to pathogens and to self-antigens. The activity of effector proteins that interact with IgM, such as complement, complement receptors, and IgMbinding agglutinins, has failed to fully account for the immune protection and regulation of immune responses mediated by IgM (9, 10) . Particularly, the role of the Fc receptor for IgM (FcμR), which is likely a key player in these IgM-mediated effector functions, is completely unknown. Although FcRs for switched Ig isotypes have been extensively characterized at both protein and genetic levels (11) , an FcμR has defied identification until our recent functional cloning of the FCMR gene (12) .
FcμR is a transmembrane sialoglycoprotein of ∼60 kDa that contains an extracellular Ig-like domain homologous to two other IgM-binding receptors, the polymeric Ig receptor (pIgR) and the FcR for IgM and polymeric IgA (Fcα/μR). However, unlike these receptors, FcμR exhibits an exclusive binding specificity for the Fc region of IgM (12) . Distinct from other FcRs, the major cell types constitutively expressing FcμR in humans are the adaptive immune cells, B and T lymphocytes. natural killer (NK) cells, which are now considered to have features of both adaptive and innate cells (13) , also express FcμR, albeit at very low levels, and are the only known example of FcμR expression by cells other than B and T cells (12) . In contrast to human FcμR, our initial immunofluorescence analysis of mouse FcμR with a receptor-specific mAb (4B5) revealed that FcμR was expressed by B cells, but not by T cells or NK cells (12, 14) . In the present studies we have conducted a comprehensive cellular analysis of FcμR expression in mice with new receptor-specific mAbs and have explored the in vivo function of the receptor by determining the consequences of an Fcmr null mutation.
Results
Confirmation of Fcmr Ablation. We generated FcμR-deficient mice in which the Fcmr gene was disrupted by replacing exons 2-4 (corresponding to a part of the signal peptide and the most extracellular region including the IgM-binding Ig-like domain) with a Neo gene. Fcmr heterozygous mice were backcrossed onto a C57BL/6 background for more than eight generations, and Fcmrdeficient homozygous (KO) mice were produced in the expected Mendelian ratio from heterozygous crossbreeding (Fcmr +/+ : 20%; Fcmr +/− : 49%; Fcmr −/− : 31%; Fig. S1 ). Fcmr KO mice were indistinguishable from littermates with respect to appearance, general behavior, body and organ weights, and fertility. Ablation of the Fcmr was confirmed by the absence of FcμR proteins and full-length FcμR transcripts ( Fig. 1 and Fig. S2, respectively) . Fcmr +/+ littermates were used as WT controls in this study.
FcμR Expression Within B-Cell Subsets. In our previous studies with the 4B5 rat mAb, the expression of FcμR in mice, unlike humans, was found to be restricted to B cells (14) . 
prepared, marrow CD11b
+ myeloid cells (Fig. 1E) or by macrophage colony-stimulating factor (M-CSF)-induced bone marrow macrophages. The lack of FcμR expression by non-Bcell populations was also confirmed by RT-PCR analysis (Fig. S2 ).
There was a hierarchy of mean fluorescence intensity ( (Fig. 1D ). The majority of CD138
+ plasma cells in spleen and lymph nodes expressed FcμR, whereas only a fraction of the CD138 + cells, which express high levels of CD19 or B220, in bone marrow were positive ( Fig. 1F and Fig. S4 ), suggesting that FcμR is expressed by plasmablasts rather than plasma cells. Collectively, these findings clearly demonstrate that the expression of FcμR in mice is restricted to B-lineage cells, beginning at the early immature B-cell stage in bone marrow and continuing through to the terminally differentiated plasma cell stage of differentiation, accompanied by downmodulation of FcμR during the GC reaction.
Alteration of B-Cell Subpopulations in Fcmr-Deficient Mice. To examine whether Fcmr deficiency leads to alterations in the development of B and T cells, each cell compartment of mutant or WT control mice of the same age and sex was evaluated. The total number of splenic T and B cells was indistinguishable in both groups of mice (Dataset S1). However, the number of CD23 − / CD21 hi or CD1d + /CD5 lo MZ [or regulatory (15) ] B cells, which constitute 5-8% of the splenic B cells in WT mice, was reduced by fourfold in the mutant mice (P < 0.01; Fig. 2A and Dataset S1). Splenic B1 cells were increased by approximately twofold in mutant mice (P < 0.01). In the peritoneal cavity, the total numbers of B1a, B1b, and B2 cells were comparable in both groups of mice, but intriguingly, the number of T cells was increased by approximately twofold in mutant mice compared with WT controls (P < 0.01; Dataset S1). The numbers of pro-B/pre-B, immature B, and recirculating B cells as well as of myeloid cells in bone marrow were identical in both groups of mice. In addition to the changes in cell numbers, there were some differences in the density of certain cell surface markers between mutant and WT controls. The CD19 levels on splenic B cells were indistinguishable, but the CD21 and CD23 levels were slightly lower in mutant mice than in WT controls (Fig. 2B) . A similar trend was also observed with the CD11b and CD5 on peritoneal B1a cells. The surface density of IgM or IgD on splenic B cells was comparable in both groups of mice. Collectively, these findings suggest that Fcmr ablation does not significantly affect overall B-and T-cell development, but alters numbers of B-cell subpopulations, accompanied by a change in the density of surface expression of certain markers on B cells.
Elevated Serum IgM Levels in Naïve Fcmr-Deficient Mice. To determine whether Fcmr deficiency affects preimmune Ig isotype levels, sera from age-matched, naïve mutant, and WT control mice were examined by ELISA. Both IgM and IgG3 levels were twofold higher in mutant mice than WT controls: 857 ± 298 μg/mL vs. 431 ± 297 μg/mL for IgM (mean ± 1 SD; P < 10 1292 μg/mL vs. 567 ± 350 μg/mL for IgG3 (P < 0.003) (Fig. 3) .
To determine whether Fcmr ablation affects the half-life of IgM, we first examined the expression of FcμR by liver sinusoidal endothelial cells (LSECs), which are thought to be the primary site of IgM catabolism, at least in the rat (16) . Liver and spleen from WT, Rag1 KO (to avoid contamination with FcμR + B cells), and Fcmr KO were examined by both immunohistological and RT-PCR analyses. There was no expression of FcμR by endothelial cells including LSECs or by phagocytic cells including Kupffer cells (Fig. S2) , thus further supporting the B-cell-restricted expression of FcμR. Next, the half-life of injected IgM a in mutant and WT control mice was assessed by ELISA using a mAb specific for the IgM a allotype and was found to be comparable (Fig. S5 ). These findings suggest that the increase of serum IgM levels in naïve Fcmr KO mice may be the consequence of FcμR-mediated regulation of IgM production at the B-or plasma-cell stage.
Elevated Natural Antibodies in Fcmr-Deficient Mice. Ca 2+ mobilization upon either ligation of B-cell Ag receptor (BCR) with anti-μ mAb or coligation of BCR and FcμR in vitro was comparable between WT and FcμR-deficient B cells (Fig. S6) . We next determined whether the elevated serum levels of IgM and IgG3 in naïve Fcmr KO mice are accompanied by an increase in natural Abs. Immunofluorescence analysis for the presence of antinuclear and cytoplasmic autoantibodies with the use of HEp-2 cells showed that naïve mutant mouse sera displayed various staining patterns including homogeneous or speckled nuclear and cytoplasmic staining (Fig. 4A) . Most (4/5) mutant sera contained IgM and IgG2c Abs reactive with either the nucleus or cytoplasm of HEp-2 cells even at a 32-fold dilution or more, whereas none of WT sera displayed any reactivity at a 1:16 dilution. All mutant mouse sera also contained variable titers of IgG3 Abs with similar staining patterns as IgM and IgG2c Abs. To further assess the natural Abs, we determined the levels of autoantibodies to dsDNA and chromatin in naïve mice of 10-15 wk by ELISA. Both IgM and IgG anti-dsDNA and antichromatin Abs were significantly elevated in Fcmr KO mice (Fig. 4B) . This increase was observed with IgG2c Abs to both autoantigens and IgG3 Abs 2 cfu) of a live nonencapsulated (avirulent) strain of Streptococcus pneumoniae (R36A), and 4 wk later were boosted i.p. with 10 2 live R36A. Serum Abs against the following three different Ags were assessed weekly by ELISA for 8 wk: as a T-cell independent type 2 (TI-2) Ag, phosphorylcholine (PC), and as T-cell-dependent (TD) Ags, R36A-associated crude proteins and recombinant PspA proteins (17) . As shown in Fig. 5A , IgM and IgG3 PC-specific responses were comparable within both groups of mice when immunized with 10 6 or more bacteria. By contrast, at a suboptimal dose of R36A (10 4 cfu) both IgM and IgG3 PC-specific Abs were markedly elevated in mutant mice. Notably, a large fraction of anti-PC Abs in both groups of mice was positive for the T15 idiotype, suggesting that typical PC responses were being induced. Prolonged and significantly higher levels of IgM anti-PC were observed in mutant mice immunized even with 10 2 cfu. In contrast to PC responses, IgM and IgG responses against R36A-associated protein determinants were generally indistinguishable between mutant and WT control mice, except that a slight increase of IgM Abs was observed in mutant mice at suboptimal Ag doses (10 4 and 10 2 cfu; Fig. 5B ). IgG1, IgG2b, and IgG2c Abs developed only in mice receiving higher Ag doses (≥10 6 cfu) and the booster injection with 10 2 cfu did not induce a recall response to protein determinants in either group of mice. Unlike the IgG3 anti-PC response, protein-specific IgG3 Abs were also comparable in both groups of mice at all four different Ag doses. IgM and IgG Ab responses to PspA were essentially the same as those to R36A crude proteins (Fig. S7) .
Thus, these results demonstrate that after immunization with live attenuated bacteria, Fcmr ablation affects PC-specific Ab responses more profoundly than protein-specific ones, suggesting a preferential regulatory role of FcμR on B and/or plasma cells in TI type 2 immune responses.
Next, to determine whether Fcmr ablation influences the affinity maturation of Abs, we used the well-characterized haptencarrier conjugate system, nitrophenyl-coupled chicken γ-globulin (NP-CGG), as another TD Ag. Mice were immunized i.p. with three different doses (100, 10, and 1 μg) of NP23-CGG precipitated in alum, and 6 wk later the immunized animals were boosted i.p. with the same dose of NP23-CGG in PBS as the primary injection. Notably, preimmune or natural IgM anti-NP Ab was significantly higher in mutant mice than WT controls (Fig. 6A) (Fig. 6B) . For Ab affinity assessment, we first quantified serum Abs reactive with NIP25-BSA and NIP5-BSA at three different time points during immunization and the ratio of anti-NIP25 Ab to anti-NIP5 Ab was used as a relative affinity maturation index. As shown in Fig. 6C , there were no significant differences in the affinity indices of anti-NP Abs between mutant and WT mice, suggesting that Fcmr disruption did not influence Ab affinity maturation. Thus, these findings demonstrated that: (i) upon immunization with NP-CGG, Fcmr KO mice had diminished primary IgG1 and secondary IgM responses to both NP and CGG compared with WT control mice, suggesting different outcomes of Fcmr ablation in TD immune responses depend on the form of the antigen, isolated (NP-CGG) versus particulate, bacteriaassociated proteins (R36A proteins/PspA), and (ii) Fcmr ablation does not influence antibody affinity maturation.
Discussion
The goal of these studies was to define the precise cellular distribution of mouse FcμR using new receptor-specific mAbs and to explore its in vivo function by examining the phenotype of FcμR-deficient mice. Unlike in humans, the FcμR in mice was only expressed by B-lineage cells, beginning at the immature B-cell stage in bone marrow and continuing through to the terminally differentiated plasma-cell stage. The surface receptor expression was highest on FO B cells and was transiently down-modulated during the GC reactions, before returning to starting levels on memory B and plasma cells. FcμR ablation (i) did not grossly affect overall B-and T-cell development, but resulted in a fourfold reduction of MZ B cells and a twofold increase in splenic B cells; (ii) led to an approximately twofold increase in the concentration of IgM in preimmune sera accompanied by an increase in natural autoantibodies; (iii) resulted in robust and long-lasting anti-PC Ab responses, especially when suboptimal doses of live avirulent pneumococci were injected i.p.; and (iv) caused impaired TD Ab responses, especially primary IgG1 responses, when immunized with a non-bacteria-associated form of TD Ag. The finding of elevated serum IgM in naïve Fcmr KO mice is remarkable. Because serum IgM was not affected in mice with null mutations of other IgM-binding receptors, pIgR on mucosal epithelial cells or Fcα/μR on follicular dendritic cells (18, 19) , the FcμR appears to be the sole receptor in this family that may be involved in maintenance of serum IgM levels within the physiological range. Because the half-life of the injected IgM is the same in Fcmr KO and WT control mice, FcμR does not appear to be involved in IgM catabolism likely mediated by LSECs, but rather is involved in the production and/or secretion of IgM by B and/or plasma cells. In humans, chronic lymphocytic leukemia (CLL) B cells overexpress cell surface FcμR and rapidly ingest IgM ligands through this receptor (20, 21) . Curiously, as many CLL patients have reduced serum Ig levels including IgM, it would be worthwhile to determine whether this reduction is related to the enhanced expression of FcμR on the leukemic B cells. The concomitant increase in serum IgG3 levels in naïve Fcmr KO mice may suggest the possibility of FcμR-mediated regulation in IgM production and/or secretion by B or plasma cells, probably down-regulating more selectively TI Ab responses, as discussed below. Notably, serum IgM levels in mice raised under germ-free conditions are similar to those in mice held under conventional or specific pathogen-free housing conditions (22, 23) . The preimmune natural IgM might be the consequence of exposure to self-Ags associated with cell corpses and B1 cells are a major source of natural IgM Abs (24), consistent with our findings that the Fcmr KO mice have a twofold increase over WT controls of B1 cells in spleen and elevated levels of natural autoantibodies to nuclear or cytoplasmic components. It will be important to determine whether this increase facilitates autoimmune processes in such mutant mice. The inhibitory FcγR, FcγRIIb, is expressed on long-lived plasma cells in bone marrow and its cross-linking induces their apoptosis, thereby controlling their homeostasis (25) . Because FcμR is expressed by CD19 hi or B220 hi plasmablasts, the functional role of FcμR in these marrow Ab-producing cells remains to be elucidated.
Another remarkable finding is an enhanced PC-specific, but not protein-specific, Ab response in Fcmr KO mice upon i.p. administration of live R36A. PC is an immunodominant epitope on the pneumococcal cell wall polysaccharide (26, 27) and is generally considered as a TI-2 Ag, although a distinct type of T-cell help, different from that in classical TD Ab responses, has been proposed to influence this type of response (28) . The molecular basis for the selective enhancement of the anti-PC response in the Fcmr KO mice remains to be elucidated; however, several possibilities are worth consideration. First, given such a persistent Ab response, PC-containing polysaccharides may be retained and stimulate B1 or MZ B cells for a longer period in mutant mice than in WT controls. Upon i.p. injection of R36A, phagocytes in the peritoneal cavity of both groups of mice must ingest bacteria after opsonization at an equivalent level, because FcμR is not expressed by these cells. Among the phagocytes, dendritic cells (DCs) are known to be crucial for priming TI-2 immune responses by interacting locally with peritoneal B1 cells or by migrating to and interacting with splenic MZ B cells (29 were quantified weekly by ELISA in triplicate using plates precoated with PC-BSA or R36A-derived crude proteins and AP-labeled goat Abs specific for each Ig isotype. PC-specific IgM (BH8) and IgG3 (HPCG11) mAbs and mouse antisera against R36A were used as Ig standards. Data are plotted as mean ± SE. *P < 0.05, **P < 0.01, and ***P < 0.001, respectively. . The affinity measurement of anti-NP Abs (C) was assessed by ELISA using plates precoated with NIP25-BSA or NIP5-BSA. NP-specific IgM (B1-8), low-affinity IgG1 (N1G9), and high-affinity IgG1 (H33L) mAbs were used as standards. *P < 0.05 and **P < 0.01, respectively. Note diminished primary IgG1 responses to NP and CGG in FcμR-deficient mice.
On the other hand, when immunized with NP-CGG precipitated in alum, Fcmr KO mice had impaired primary IgG1 and secondary IgM NP-specific responses, even though they had elevated IgM natural anti-NP Abs compared with WT controls. Notably, mice deficient in IgM secretion also displayed a reduced primary IgG1 anti-NP Ab response, which could be corrected by administration of pooled serum IgM (3). Thus, FcμR-mediated signals might be crucial for potentiating the initial IgG1 anti-NP Ab responses. It has also been shown that there are fundamental differences in immune responses to an isolated protein or polysaccharide Ag versus an intact extracellular bacterium (28, 40) . Intact bacteria are complex particulate immunogens on which multiple proteins and polysaccharide Ags and TLR ligands (TLRLs) are coexpressed. TLRLs are well known to enhance immune responses, although the role of TLRs in B-cell activation and Ab production is not fully understood with conflicting results (41) (42) (43) . The differences in TD Ab responses to R36A proteins versus NP-CGG in mutant mice might be due to the different antigenic forms, bacteria associated versus isolated.
In this study, we show that FcμR is expressed only by B-lineage cells in mice. The null mutation of Fcmr leads to elevation in preimmune serum IgM levels accompanied by an increase in natural autoantibodies and to altered humoral immune responses characterized by robust and long-lasting PC-specific, but not protein-specific, Ab responses after i.p. immunization with live avirulent S. pneumoniae. This mutant strain of mice would thus be valuable for investigating IgM-mediated immune protection and regulation of immune responses. Although FCMR deficiency has not yet been identified in humans, it seems likely that the phenotype will be much more complex and profound than that of the FcμR deficiency described here, because the human FcμR is expressed by additional cell types, namely T and NK cells (12) . However, the results from the present studies provide some hints regarding the potential phenotype of FCMR deficiency.
Materials and Methods
SI Materials and Methods provides complete experimental methods. These include genotyping of offspring from breeding Fcmr +/− mice, production of anti-FcμR mAbs, and other mAbs and reagents, flow cytometric analysis, immunization of Ags, ELISA, detection of natural Abs, IgM catabolism, and calcium mobilization analysis. Statistical analysis of results is also included.
